Nasdaq rejects Massroots IPO
The cannabis social network Massroots, has been refused a listing on the Nasdaq, the US high-tech industry's stock exchange. The site had applied for an IPO in April.
With 775,000 users, the app that brings cannabis consumers together is currently valued at $40 million. Despite the growing number of States legalizing cannabis use. At present, 25 states have legalized medical use and 4 have legalized recreational use.
Despite the market's expansion, investors did not take kindly to the network's main focus: the Cannabis. The company comments on its web page, «On May 23, 2016, Nasdaq denied the Massroots app a listing on its exchanges because it is cannabis-related.« ,
«We believe this dangerous precedent could prevent just about any company in the regulated cannabis industry from listing on a national exchange, making it harder for cannabis entrepreneurs to raise capital and slowing the progress of legalization in the US.»
Isaac Dietrich, CEO of the start-up, says he will appeal the decision. The challenge for him and his company is to maintain the economic health of his application until the referendums on cannabis legalization that will be held in various states, notably the huge California market. Investors could open their eyes to the economic potential of green gold.
-
Cannabis in France4 weeks ago
France Sets July as the Deadline for the Widespread Adoption of Medical Cannabis
-
Cannabis in Europe2 weeks ago
Bosnia and Herzegovina Continues to Roll Out Medical Cannabis Following Its Legalization
-
Cannabis in France2 weeks ago
France Submits the Long-Awaited Decree on the Reimbursement of Medical Cannabis to the Council of State
-
Cannabis in the U.S.2 weeks ago
The DEA Begins Hearings on the Federal Rescheduling of Cannabis
-
Cannabis in Ireland3 weeks ago
The Irish Parliament recommends decriminalizing all drugs
-
Business4 weeks ago
Sanity Group is expanding its presence in Switzerland through a distribution agreement with Astrasana
-
Cannabis in France4 weeks ago
Medical Cannabis in France: What the First Major Study Reveals About Its Actual Impact
-
Cannabis in Switzerland3 weeks ago
St. Gallen, Switzerland, Launches Its 8th Legal Cannabis Pilot Project


gh0stwrit3r
2 June 2016 at 9 h 06 min
We accept money from sellers of weapons, a product that kills people, and we refuse to accept money from this site just because it talks about medicinal and recreational cannabis.